Literature DB >> 18923023

Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum.

Akinori Nishi1, Mahomi Kuroiwa, Diane B Miller, James P O'Callaghan, Helen S Bateup, Takahide Shuto, Naoki Sotogaku, Takaichi Fukuda, Nathaniel Heintz, Paul Greengard, Gretchen L Snyder.   

Abstract

Phosphodiesterase (PDE) is a critical regulator of cAMP/protein kinase A (PKA) signaling in cells. Multiple PDEs with different substrate specificities and subcellular localization are expressed in neurons. Dopamine plays a central role in the regulation of motor and cognitive functions. The effect of dopamine is largely mediated through the cAMP/PKA signaling cascade, and therefore controlled by PDE activity. We used in vitro and in vivo biochemical techniques to dissect the roles of PDE4 and PDE10A in dopaminergic neurotransmission in mouse striatum by monitoring the ability of selective PDE inhibitors to regulate phosphorylation of presynaptic [e.g., tyrosine hydroxylase (TH)] and postsynaptic [e.g., dopamine- and cAMP-regulated phosphoprotein of M(r) 32 kDa (DARPP-32)] PKA substrates. The PDE4 inhibitor, rolipram, induced a large increase in TH Ser40 phosphorylation at dopaminergic terminals that was associated with a commensurate increase in dopamine synthesis and turnover in striatum in vivo. Rolipram induced a small increase in DARPP-32 Thr34 phosphorylation preferentially in striatopallidal neurons by activating adenosine A(2A) receptor signaling in striatum. In contrast, the PDE10A inhibitor, papaverine, had no effect on TH phosphorylation or dopamine turnover, but instead robustly increased DARPP-32 Thr34 and GluR1 Ser845 phosphorylation in striatal neurons. Inhibition of PDE10A by papaverine activated cAMP/PKA signaling in both striatonigral and striatopallidal neurons, resulting in potentiation of dopamine D(1) receptor signaling and inhibition of dopamine D(2) receptor signaling. These biochemical results are supported by immunohistochemical data demonstrating differential localization of PDE10A and PDE4 in striatum. These data underscore the importance of individual brain-enriched cyclic-nucleotide PDE isoforms as therapeutic targets for neuropsychiatric and neurodegenerative disorders affecting dopamine neurotransmission.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18923023      PMCID: PMC2814340          DOI: 10.1523/JNEUROSCI.2518-08.2008

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  45 in total

Review 1.  The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics?

Authors:  M L Wadenberg; P B Hicks
Journal:  Neurosci Biobehav Rev       Date:  1999       Impact factor: 8.989

2.  Focused microwave irradiation of the brain preserves in vivo protein phosphorylation: comparison with other methods of sacrifice and analysis of multiple phosphoproteins.

Authors:  James P O'Callaghan; Krishnan Sriram
Journal:  J Neurosci Methods       Date:  2004-05-30       Impact factor: 2.390

3.  Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and[3H]rolipram binding autoradiography. Comparison with monkey and rat brain.

Authors:  S Pérez-Torres; X Miró; J M Palacios; R Cortés; P Puigdoménech; G Mengod
Journal:  J Chem Neuroanat       Date:  2000-12       Impact factor: 3.052

4.  Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum.

Authors:  D Hervé; C Le Moine; J C Corvol; L Belluscio; C Ledent; A A Fienberg; M Jaber; J M Studler; J A Girault
Journal:  J Neurosci       Date:  2001-06-15       Impact factor: 6.167

5.  Deletion of phosphodiesterase 4D in mice shortens alpha(2)-adrenoceptor-mediated anesthesia, a behavioral correlate of emesis.

Authors:  Annette Robichaud; Panagiota B Stamatiou; S-L Catherine Jin; Nicholas Lachance; Dwight MacDonald; France Laliberté; Susana Liu; Zheng Huang; Marco Conti; Chi-Chung Chan
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

6.  Phosphodiesterase inhibitors: a novel mechanism for receptor-independent antipsychotic medications.

Authors:  C R Maxwell; S J Kanes; T Abel; S J Siegel
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

7.  Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs.

Authors:  Helen S Bateup; Per Svenningsson; Mahomi Kuroiwa; Shiaoching Gong; Akinori Nishi; Nathaniel Heintz; Paul Greengard
Journal:  Nat Neurosci       Date:  2008-07-11       Impact factor: 24.884

8.  Phosphodiesterase 1B knock-out mice exhibit exaggerated locomotor hyperactivity and DARPP-32 phosphorylation in response to dopamine agonists and display impaired spatial learning.

Authors:  Tracy M Reed; David R Repaske; Gretchen L Snyder; Paul Greengard; Charles V Vorhees
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

9.  Pharmacological discrimination of protein kinase associated exocytosis mechanisms between dopamine and 3,4-dihydroxyphenylalanine in rat striatum using in vivo microdialysis.

Authors:  Gang Zhu; Motohiro Okada; Shukuko Yoshida; Shinichi Hirose; Sunao Kaneko
Journal:  Neurosci Lett       Date:  2004-06-10       Impact factor: 3.046

Review 10.  DARPP-32: an integrator of neurotransmission.

Authors:  Per Svenningsson; Akinori Nishi; Gilberto Fisone; Jean-Antoine Girault; Angus C Nairn; Paul Greengard
Journal:  Annu Rev Pharmacol Toxicol       Date:  2004       Impact factor: 13.820

View more
  90 in total

1.  Roles of fragile X mental retardation protein in dopaminergic stimulation-induced synapse-associated protein synthesis and subsequent alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) receptor internalization.

Authors:  Hansen Wang; Susan S Kim; Min Zhuo
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

2.  Role of adrenoceptors in the regulation of dopamine/DARPP-32 signaling in neostriatal neurons.

Authors:  Masato Hara; Ryuichi Fukui; Eriko Hieda; Mahomi Kuroiwa; Helen S Bateup; Tatsuhiko Kano; Paul Greengard; Akinori Nishi
Journal:  J Neurochem       Date:  2010-03-04       Impact factor: 5.372

3.  Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex.

Authors:  Mahomi Kuroiwa; Gretchen L Snyder; Takahide Shuto; Atsuo Fukuda; Yuchio Yanagawa; David R Benavides; Angus C Nairn; James A Bibb; Paul Greengard; Akinori Nishi
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

4.  Chronic exposure to corticosterone enhances the neuroinflammatory and neurotoxic responses to methamphetamine.

Authors:  Kimberly A Kelly; Diane B Miller; John F Bowyer; James P O'Callaghan
Journal:  J Neurochem       Date:  2012-08-03       Impact factor: 5.372

5.  Inhibition of Phosphodiesterase 10A Increases the Responsiveness of Striatal Projection Neurons to Cortical Stimulation.

Authors:  Sarah Threlfell; Stephen Sammut; Frank S Menniti; Christopher J Schmidt; Anthony R West
Journal:  J Pharmacol Exp Ther       Date:  2008-12-04       Impact factor: 4.030

6.  In Vivo Characterization of Two 18F-Labeled PDE10A PET Radioligands in Nonhuman Primate Brains.

Authors:  Hui Liu; Hongjun Jin; Zonghua Luo; Xuyi Yue; Xiang Zhang; Hubert Flores; Yi Su; Joel S Perlmutter; Zhude Tu
Journal:  ACS Chem Neurosci       Date:  2018-02-19       Impact factor: 4.418

7.  The phosphodiesterase-4 inhibitor roflumilast decreases ethanol consumption in C57BL/6J mice.

Authors:  Xin Liu; Pi-Da Hao; Ming-Feng Yang; Jing-Yi Sun; Lei-Lei Mao; Cun-Dong Fan; Zong-Yong Zhang; Da-Wei Li; Xiao-Yi Yang; Bao-Liang Sun; Han-Ting Zhang
Journal:  Psychopharmacology (Berl)       Date:  2017-05-06       Impact factor: 4.530

8.  Radiosynthesis and in vivo evaluation of [11C]MP-10 as a PET probe for imaging PDE10A in rodent and non-human primate brain.

Authors:  Zhude Tu; Jinda Fan; Shihong Li; Lynne A Jones; Jinquan Cui; Prashanth K Padakanti; Jinbin Xu; Dexing Zeng; Kooresh I Shoghi; Joel S Perlmutter; Robert H Mach
Journal:  Bioorg Med Chem       Date:  2011-01-22       Impact factor: 3.641

9.  Phosphodiesterase 10A Is Tethered to a Synaptic Signaling Complex in Striatum.

Authors:  Corina Russwurm; Doris Koesling; Michael Russwurm
Journal:  J Biol Chem       Date:  2015-03-11       Impact factor: 5.157

10.  The internal state of medium spiny neurons varies in response to different input signals.

Authors:  Zhen Qi; Gary W Miller; Eberhard O Voit
Journal:  BMC Syst Biol       Date:  2010-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.